TrialThe New England journal of medicine2021
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.
Raphael J Landovitz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
545 papers cite itlatest 60 shown
this paperpooled ittrialcites it